The effect of opioid dependence on conventional and novel biochemical parameters of bone metabolism

References

• Daniell HW. Opioid osteoporosis. Arch Intern Med 2004;164:338
   PubMed Web of Science ®Google Scholar
• Rhodin A, Stridsberg M, Gordh T. Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment. Clin J Pain 2010;26:374–380
   PubMed Web of Science ®Google Scholar
• Coluzzi F, Pergolizzi J, Raffa RB, Mattia C. The unsolved case of “bone-impairing analgesics”: the endocrine effects of opioids on bone metabolism. Ther Clin Risk Manag 2015;11:515–523
   PubMed Web of Science ®Google Scholar
• Petrizzi L, Mariscoli M, Valbonetti L, Varasano V, Langhoff JD, Von Rechenberg B. Preliminary study on the effect of parenteral naloxone, alone and in association with calcium gluconate, on bone healing in an ovine “drill hole” model system. BMC Musculoskelet Disord 2007;8:43
   PubMed Web of Science ®Google Scholar
• Perez-Castrillon JL, Olmos JM, Gomez JJ, Barrallo A, Riancho JA, Perera L, Valero C, et al. Expression of opioid receptors in osteoblast-like MG-63 cells, and effects of different opioid agonists on alkaline phosphatase and osteocalcin secretion by these cells. Neuroendocrinology 2000;72:187–194
   PubMed Web of Science ®Google Scholar
• Pedrazzoni M, Vescovi PP, Maninetti L, Michelini M, Zaniboni G, Pioli G, Costi D, et al. Effects of chronic heroin abuse on bone and mineral metabolism. Acta Endocrinol (Copenh) 1993;129:42–45
   PubMedGoogle Scholar
• Abs R, Verhelst J, Maeyaert J, Van Buyten JP, Opsomer F, Adriaensen H, Verlooy J, et al. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 2000;85:2215–2222
   PubMed Web of Science ®Google Scholar
• Daniell HW. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain. J Pain 2008;9:28–36
   PubMed Web of Science ®Google Scholar
• Reddy RG, Aung T, Karavitaki N, Wass JAH. Opioid induced hypogonadism. BMJ 2010;341:c4462
   PubMed Web of Science ®Google Scholar
• Vuong C, Van Uum SH, O’Dell LE, Lutfy K, Friedman TC. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev 2010;31:98–132
   PubMed Web of Science ®Google Scholar
• Azizi F, Vagenakis AG, Longcope C, Ingbar SH, Braverman LE. Decreased serum testosterone concentration in male heroin and methadone addicts. Steroids 1973;22:467–472
   PubMed Web of Science ®Google Scholar
• De Maddalena C, Bellini M, Berra M, Meriggiola MC, Aloisi AM. Opioid-induced hypogonadism: why and how to treat it. Pain Physician 2012;15:ES111–ES118
   Google Scholar
• Aloisi AM, Aurilio C, Bachiocco V, Biasi G, Fiorenzani P, Pace MC, Paci V, et al. Endocrine consequences of opioid therapy. Psychoneuroendocrinology 2009;34:162–168
   Google Scholar
• Duarte RV, Raphael JH, Southall JL, Labib MH, Whallett AJ, Ashford RL. Hypogonadism and low bone mineral density in patients on long-term intrathecal opioid delivery therapy. BMJ Open 2013;3:e002856
   Google Scholar
• Dürsteler-MacFarland KM, Kowalewski R, Bloch N, Wiesbeck GA, Kraenzlin ME, Stohler R. Patients on injectable diacetylmorphine maintenance have low bone mass. Drug Alcohol Rev 2011;30:577–582
   PubMed Web of Science ®Google Scholar
• Kim TW, Alford DP, Malabanan A, Holick MF, Samet JH. Low bone density in patients receiving methadone maintenance treatment. Drug Alcohol Depend 2006;85:258–262
   PubMed Web of Science ®Google Scholar
• Grey A, Rix-Trott K, Horne A, Gamble G, Bolland M, Reid IR. Decreased bone density in men on methadone maintenance therapy. Addiction 2011;106:349–354
   PubMed Web of Science ®Google Scholar
• Dolan SE, Huang JS, Killilea KM, Sullivan MP, Aliabadi N, Grinspoon S. Reduced bone mineral density in HIV-infected women. AIDS 2004;18:475–483
   PubMed Web of Science ®Google Scholar
• Amorosa V, Tebas P. Bone disease and HIV infection. Clin Infect Dis 2006;42:108–114
   PubMed Web of Science ®Google Scholar
• Hummer M, Malik P, Gasser RW, Hofer A, Kemmler G, Moncayo Naveda RC, Rettenbacher MA, Fleischhacker W. Osteoporosis in patients with schizophrenia. Am J Psychiatry 2005;162:162–167
   PubMed Web of Science ®Google Scholar
• Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, DeMarco D, Hoffmann M, Tebas P. Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis 2003;36:482–490
   PubMed Web of Science ®Google Scholar
• Sharma A, Cohen HW, Freeman R, Santoro N, Schoenbaum EE. Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: association between methadone use and bone loss. Maturitas 2011;70:295–301
   PubMed Web of Science ®Google Scholar
• Gallego-Rojo FJ, Gonzalez-Calvin JL, Munoz-Torres M, Mundi JL, Fernandez-Perez R, Rodrigo-Moreno D. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998;28:695–699
   PubMed Web of Science ®Google Scholar
• Iber F. Bone disease in chronic liver disease. Am J Gastroenterol. 1989;84:1229–1230
   PubMed Web of Science ®Google Scholar
• Brown R. Heroin dependence. WMJ 2004;103:20–26
   PubMedGoogle Scholar
• Roy S, Ninkovic J, Banerjee S, Charboneau RG, Das S, Dutta R, Kirchner VA, et al. Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections. J Neuroimmune Pharmacol 2011;6:442–465
   PubMed Web of Science ®Google Scholar
• Sharma A, Flom PL, Weedon J, Klein RS. Prospective study of bone mineral density changes in aging men with or at risk for HIV infection. AIDS 2010;24:2337–2345
   PubMed Web of Science ®Google Scholar
• Bergmann P, Body JJ, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, Kaufman JM, et al; Members of Advisory Board on Bone Markers. Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club. Int J Clin Pract 2009;63:19–26
   PubMed Web of Science ®Google Scholar
• Garnero P. New developments in biological markers of bone metabolism in osteoporosis. Bone 2014;66:46–55
   PubMed Web of Science ®Google Scholar
• Vasikaran S, Eastell R, Bruyère O, Foldes AJ, Garnero P, Griesmacher A, McClung M, et al; IOF-IFCC Bone Marker Standards Working Group. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 2011;22:391–420
   PubMed Web of Science ®Google Scholar
• Krege JH, Lane NE, Harris JM, Miller PD. PINP as a biological response marker during teriparatide treatment for osteoporosis. Osteoporos Int 2014;25:2159–2171
   PubMed Web of Science ®Google Scholar
• Eastell R, Krege JH, Chen P, Glass EV, Reginster JY. Development of an algorithm for using PINP to monitor treatment of patients with teriparatide. Curr Med Res Opin 2006;22:61–66
   PubMed Web of Science ®Google Scholar
• Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J. The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporo Int 2000;11:S2–S17
   PubMedGoogle Scholar
• Christgau S, Bitsch-Jensen O, Hanover Bjarnason N, Gamwell Henriksen E, Qvist P, Alexandersen P, Bang Henriksen D. Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy. Bone 2000;26:505–511
   PubMed Web of Science ®Google Scholar
• Garnero P, Borel O, Delmas PD. Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis. Clin Chem 2001;47:694–702
   PubMed Web of Science ®Google Scholar
• Okabe R, Nakatsuka K, Inaba M, Miki T, Naka H, Masaki H, Moriguchi A, Nishizawa Y. Clinical evaluation of the elecsys B-crosslaps serum assay, a new assay for degradation products of type I collagen C-telopeptides. Clin Chem 2001;47:1410–1414
   PubMed Web of Science ®Google Scholar
• McLellan A, Luborsky L, Cacciola J, Griffith J, Evans F, Barr H, O’Brien C. New data from the Addiction Severity Index: reliability and validity in three centers. J Nerv Ment Dis 1985;173:412–423
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders 4th ed. Washington (DC): APA; 1994
   Google Scholar
• Pedrazzoni M, Vescovi PP, Maninetti L, Michelini M, Zaniboni G, Pioli G, Costi D, et al. Effects of chronic heroin abuse on bone and mineral metabolism. Acta Endocrinol (Copenh) 1993;129:42–45
   PubMedGoogle Scholar
• Grzeszczak W, Kokot F, Duława J. Effects of naloxone administration on endocrine abnormalities in chronic renal failure. Am J Nephrol 1987;7:93–100
   PubMed Web of Science ®Google Scholar
• Merza Z. Chronic use of opioids and the endocrine system. Horm Metab Res 2010;42:621–626
   PubMed Web of Science ®Google Scholar
• Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 1996;11:337–349
   PubMed Web of Science ®Google Scholar
• Vasikaran SD, Glendenning P, Morris HA. The role of biochemical markers of bone turnover in osteoporosis management in clinical practice. Clin Biochem Rev 2006;27:119–121
   PubMedGoogle Scholar
• Collier J. Bone disorders in chronic liver disease. Hepatology 2007;46:1271–1278
   PubMed Web of Science ®Google Scholar
• Lin JC, Hsieh TY, Wu CC, Chen PJ, Chueh TH, Chang WK, Chu HC. Association between chronic hepatitis C virus infection and bone mineral density. Calcif Tissue Int 2012;91:423–429
   PubMed Web of Science ®Google Scholar
• El-Husseini A, Sabry A, Hassan R, Sobh M. Effect of chronic hepatitis C virus infection on bone mineral density in pediatric renal transplant recipients. Saudi J Kidney Dis Transpl 2013;24:917–924
   PubMedGoogle Scholar
• Yenice N, Gümrah M, Mehtap O, Kozan A, Türkmen S. Assessment of bone metabolism and mineral density in chronic viral hepatitis. Turk J Gastroenterol 2006;17:260–266
   PubMedGoogle Scholar